https://www.selleckchem.com/products/hrs-4642.html
Overall, over 80% were either neutral or positive about the change. Our study showed a consistently low non-compliance rate of MSM over the three periods. The generally high level of acceptance of time-limited deferral among donors lends support to science-based policy development to protect blood safety. The identification of compliant MSM donors suggests that the 12-month deferral is effective and acceptable to MSM. With a deferral period far exceeding the window period, it is a step towards a more equitable policy. Our study showed
Like
Comment
Share
